Novalent Biotech

Novalent Biotech is a private U.S. antimicrobial technology company focused on long-lasting germ protection for surfaces, skin, and textiles. The company markets proprietary products based on a patented, non-toxic monomolecular layer designed to inhibit or kill bacteria and other microorganisms for extended periods after a single application. Its offerings have been positioned for use across healthcare, food processing, animal health, hospitality, transportation, and commercial settings rather than as a traditional therapeutic drug developer. Available sources indicate the business was headquartered in Greensboro, North Carolina and sold branded antimicrobial products including BioShield 75 and BioShield 5000 C. Court records show Novalent Biotech, Inc. entered Chapter 11 bankruptcy in August 2024, so it should not be treated as an operating growth-stage biotech pipeline company.